EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Motor cortex repetitive transcranial magnetic stimulation in major depressive disorder - A preliminary randomized controlled clinical trial

Yu-Ting Hu, Xi-Wen Hu, Jin-Fang Han, Jian-Feng Zhang, Ying-Ying Wang, Annemarie Wolff, Sara Tremblay, Dusan Hirjak, Zhong-Lin Tan, Georg Northoff

Journal of Affective Disorders · 2024

DOI: 10.1016/j.jad.2023.10.058 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Yu-Ting Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Mental Health Center and Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, China; Institute of Mental …. Hauptthemen laut MEDLINE: Major Depressive Disorder, Depressive Disorder, Treatment-Resistant, Motor Cortex. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) at left dorsolateral prefrontal cortex (lDLPFC) is commonly used in major depressive disorder (MDD), even though its therapeutic efficacy is limited. Given that many MDD patients show psychomotor retardation, we aim to examine whether the left motor cortex (lMC) as a novel rTMS target would provide effective and well-tolerated treatment as being comparable to lDLPFC-rTMS. METHODS: In this prospective double-blind randomized single-center study, 131 MDD patients were randomly assigned to the lDLPFC or lMC group and were treated with 10 Hz rTMS (90 % motor threshold) applied twice daily for 4000 pulses continuously over five days. The primary endpoint was the Hamilton Depression Scale (HAMD) total score change after treatment. RESULTS: After the five-day rTMS treatment, there was no significant difference in both HAMD reduction rate (lDLPFC 59.3 % ± 20.4 %, lMC 51.3 % ± 26.3 %, P = 0.10) and adverse effects (P = 0.79) between 48 (73.8 %) lMC subjects and 51 (77.3 %) lDLPFC subjects. Furthermore, the lMC study group showed stable HAMD scores at follow-up compared to their endpoint scores (P = 0.08). LIMITATIONS: Sham-control group was not included and the sample size was small. Therefore, our results should be seen as exploratory and preliminary. CONCLUSIONS: The preliminary good therapeutic response, comparability, and tolerability of lMC-rTMS suggest lMC a potential and more easily accessible rTMS target. Together, our findings raise the possibility of symptom-specific rTMS in motor cortex (psychomotor retardation) or lDLPFC (cognitive deficits). This warrants larger clinical trials of rTMS in MDD with symptom-specific stimulation targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderDepressive Disorder, Treatment-ResistantMotor CortexHumansPrefrontal CortexProspective StudiesTranscranial Magnetic StimulationTreatment OutcomeDouble-Blind Method

Stichwörter der Autor:innen

Dorsolateral prefrontal cortexMajor depressive disorderMotor cortexRepetitive transcranial magnetic stimulation

Autor:innen und Institutionen

  • Affiliated Mental Health Center and Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, China; Institute of Mental Health Research, University of Ottawa, Ottawa, Canada.
  • Affiliated Mental Health Center and Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Center for Brain Disorders and Cognitive Sciences, Shenzhen University, Shenzhen, China.
  • Institute of Psychological Sciences, College of Education, Hangzhou Normal University, Hangzhou, China.
  • Institute of Mental Health Research, University of Ottawa, Ottawa, Canada.
  • Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Zitieren

APA

Hu, Y. T., Hu, X. W., Han, J. F., Zhang, J. F., Wang, Y. Y., Wolff, A., Tremblay, S., Hirjak, D., Tan, Z. L., & Northoff, G. (2024). Motor cortex repetitive transcranial magnetic stimulation in major depressive disorder - A preliminary randomized controlled clinical trial. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2023.10.058

Vancouver

Hu YT, Hu XW, Han JF, Zhang JF, Wang YY, Wolff A, et al. Motor cortex repetitive transcranial magnetic stimulation in major depressive disorder - A preliminary randomized controlled clinical trial. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2023.10.058

BibTeX
@article{Hu2024,
  author = {Hu, Yu-Ting and Hu, Xi-Wen and Han, Jin-Fang and Zhang, Jian-Feng and Wang, Ying-Ying and Wolff, Annemarie and Tremblay, Sara and Hirjak, Dusan and Tan, Zhong-Lin and Northoff, Georg},
  title = {Motor cortex repetitive transcranial magnetic stimulation in major depressive disorder - A preliminary randomized controlled clinical trial},
  journal = {Journal of Affective Disorders},
  year = {2024},
  doi = {10.1016/j.jad.2023.10.058}
}
Kostenlos starten →